EXELERATE CAPITAL CORP (XCAP-P.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:XCAP-P • CA30163L1031

0.045 CAD
0 (0%)
Last: Jan 29, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall XCAP-P gets a fundamental rating of 2 out of 10. We evaluated XCAP-P against 0 industry peers in the Unkown industry. XCAP-P scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XCAP-P does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • XCAP-P had negative earnings in the past year.
  • In the past year XCAP-P has reported a negative cash flow from operations.
XCAP-P.CA Yearly Net Income VS EBIT VS OCF VS FCFXCAP-P.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -20K -40K -60K -80K

1.2 Ratios

Industry RankSector Rank
ROA -6.86%
ROE -7.07%
ROIC N/A
ROA(3y)-4.4%
ROA(5y)N/A
ROE(3y)-4.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XCAP-P.CA Yearly ROA, ROE, ROICXCAP-P.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -2 -4 -6

1.3 Margins

  • XCAP-P does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XCAP-P.CA Yearly Profit, Operating, Gross MarginsXCAP-P.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The number of shares outstanding for XCAP-P has been increased compared to 1 year ago.
  • There is no outstanding debt for XCAP-P. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
XCAP-P.CA Yearly Shares OutstandingXCAP-P.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M
XCAP-P.CA Yearly Total Debt VS Total AssetsXCAP-P.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 200K 400K 600K 800K 1M

2.2 Solvency

  • An Altman-Z score of 16.00 indicates that XCAP-P is not in any danger for bankruptcy at the moment.
  • XCAP-P has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16
ROIC/WACCN/A
WACCN/A
XCAP-P.CA Yearly LT Debt VS Equity VS FCFXCAP-P.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 200K 400K 600K 800K 1M

2.3 Liquidity

  • XCAP-P has a Current Ratio of 34.00. This indicates that XCAP-P is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 34.00 indicates that XCAP-P has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 34
Quick Ratio 34
XCAP-P.CA Yearly Current Assets VS Current LiabilitesXCAP-P.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200K 400K 600K 800K 1M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • XCAP-P shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
XCAP-P.CA Price Earnings VS Forward Price EarningsXCAP-P.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XCAP-P.CA Per share dataXCAP-P.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for XCAP-P!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EXELERATE CAPITAL CORP

TSX-V:XCAP-P (1/29/2026, 7:00:00 PM)

0.045

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)01-28
Earnings (Next)05-13
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners21.95%
Ins Owner ChangeN/A
Market Cap790.20K
Revenue(TTM)N/A
Net Income(TTM)-70.00K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.86%
ROE -7.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.4%
ROA(5y)N/A
ROE(3y)-4.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 34
Quick Ratio 34
Altman-Z 16
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-272.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-272.67%
OCF growth 3YN/A
OCF growth 5YN/A

EXELERATE CAPITAL CORP / XCAP-P.CA FAQ

Can you provide the ChartMill fundamental rating for EXELERATE CAPITAL CORP?

ChartMill assigns a fundamental rating of 2 / 10 to XCAP-P.CA.


What is the valuation status of EXELERATE CAPITAL CORP (XCAP-P.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to EXELERATE CAPITAL CORP (XCAP-P.CA). This can be considered as Overvalued.


Can you provide the profitability details for EXELERATE CAPITAL CORP?

EXELERATE CAPITAL CORP (XCAP-P.CA) has a profitability rating of 0 / 10.